...
Expand |
---|
title | CDASH CM Metadata Specifications |
---|
|
Metadataspec |
---|
Order | Question Text | Prompt | Case Report Form Completion Instructions | Type | Collection Variable | Tabulation Target | Mapping Instructions | Controlled Terminology CodeList Name | Permissible Values | Pre-Populated Value |
---|
1 | Were any concomitant medications/products taken? | Any Concomitant Medications/Products | Indicate if the subject took any concomitant medications/products. If Yes, include the appropriate details where indicated on the CRF. | Text |
|
|
| (NY) |
|
|
Order | Question Text | Prompt | Case Report Form Completion Instructions | Type | Collection Variable | Tabulation Target | Mapping Instructions | Controlled Terminology CodeList Name | Permissible Values | Pre-Populated Value |
---|
2 | What is the category for the concomitant medication/product? | Concomitant Medication/Product Category | Record the medication/product category, if not pre-printed on the CRF. | CMCAT | CMCAT |
|
|
| GENERAL |
| 3 | What is the medication/product line number? | CM Line Number | If collected on the CRF, applicant may insert instructions to ensure each record has a unique identifier. | CMSPID | CMSPID |
|
|
|
|
| 4 | What was the medication/product? | Concomitant Medication/Product | Record only one medication/product per line. Provide the full trade or proprietary name of the medication/product; otherwise, record the generic name. | CMTRT | CMTRT |
|
|
|
|
| 5 | For what indication was the medication/product taken? | Indication | Record the reason the medication/product was taken based on clinical investigator's evaluation. If taken to treat a condition, and a diagnosis was made, the indication should be the diagnosis. If taken to treat a condition, and no diagnosis was made, the indication should be the signs and symptoms. If taken as prophylaxis, report as "Prophylaxis for " and include a description of the condition(s). | CMINDC | CMINDC |
|
|
|
|
| 6 | What was the individual dose of the medication/product? | Dose | Record the dose of medication/treatment per administration (e.g., 200). | CMDSTXT | CMDOSTXT OR CMDOSE | CMDOSTXT/ CMDOSE |
|
|
|
| 7 | What is the unit? | Unit | Record the dose unit of the dose of medication/product taken (e.g., mg). | CMDOSU | CMDOSU |
| (UNIT) | CAPSULE; g; IU; mg; mL; PUFF; TABLET; ug |
|
| 8 | What was the dose form of the medication/product? | Dose Form | Record the pharmaceutical dosage form (e.g., TABLET CAPSULE, SYRUP) of delivery for the medication/product taken. | CMDOSFRM | CMDOSFRM |
| (FRM) | AEROSOL; CAPSULE; CREAM; GAS; GEL; OINTMENT; PATCH; POWDER; SPRAY; SUPPOSITORY; SUSPENSION; TABLET |
|
| 9 | What was the frequency of the medication/product? | Frequency | Record how often the medication/product was taken (e.g., BID, PRN). | CMDOSFRQ | CMDOSFRQ |
| (FREQ) | BID; PRN; QD; QID; QM; QOD; TID |
|
| 10 | What was the route of administration of the medication/product? | Route | Provide the route of administration for the medication/product. | CMROUTE | CMROUTE |
| (ROUTE) | INTRALESIONAL; INTRAMUSCULAR; INTRAOCULAR; INTRAPERITONEAL; NASAL; ORAL; RECTAL; RESPIRATORY (INHALATION); SUBCUTANEOUS; TOPICAL; TRANSDERMAL; VAGINAL |
|
| 11 | What was the start date? | Start Date | Record the date the medication/treatment was first taken using this format. If the subject has been taking the medication/product for a considerable amount of time prior to the start of the study, it is acceptable to have an incomplete date. Medications/Products taken during the study are expected to have a complete start date. Prior medications/products that are exclusionary should have both a start date and an end date. | CMSTDAT | CMSTDTC |
|
|
|
|
| 12 | Is the medication ongoing? | Ongoing | Record the medication/product as ongoing if the subject has not stopped taking the medication/product at the time of data collection and the end date should be left blank. | CMONGO | CMENRF OR CMENRTPT | CMENRF or CMENRTPT | (NY) | Yes |
|
| 13 | What was the end date? | End Date | Record the date the medication/product was stopped using this format If the subject has not stopped taking the medication/product leave this field blank. | CMENDAT | CMENDTC |
|
|
Expand |
---|
title | CDASH CM Metadata Specifications |
---|
|
Metadataspec |
---|
Order | Question Text | Prompt | Case Report Form Completion Instructions | Type | Collection Variable | Tabulation Target | Mapping Instructions | Controlled Terminology CodeList Name | Permissible Values | Pre-Populated Value |
---|
2 | What is the category for the concomitant medication/product? | Concomitant Medication/Product Category | Record the medication/product category, if not pre-printed on the CRF. | CMCAT | CMCAT | GENERAL | 3 | What is the medication/product line number? | CM Line Number | If collected on the CRF, applicant may insert instructions to ensure each record has a unique identifier. | CMSPID | CMSPID | 4 | What was the medication/product? | Concomitant Medication/Product | Record only one medication/product per line. Provide the full trade or proprietary name of the medication/product; otherwise, record the generic name. | CMTRT | CMTRT | 5 | For what indication was the medication/product taken? | Indication | Record the reason the medication/product was taken based on clinical investigator's evaluation. If taken to treat a condition, and a diagnosis was made, the indication should be the diagnosis. If taken to treat a condition, and no diagnosis was made, the indication should be the signs and symptoms. If taken as prophylaxis, report as "Prophylaxis for " and include a description of the condition(s). | CMINDC | CMINDC | 6 | What was the individual dose of the medication/product? | Dose | Record the dose of medication/treatment per administration (e.g., 200). | CMDSTXT | CMDOSTXT OR CMDOSE | CMDOSTXT/ CMDOSE | 7 | What is the unit? | Unit | Record the dose unit of the dose of medication/product taken (e.g., mg). | CMDOSU | CMDOSU | (UNIT) | CAPSULE; g; IU; mg; mL; PUFF; TABLET; ug | 8 | What was the dose form of the medication/product? | Dose Form | Record the pharmaceutical dosage form (e.g., TABLET CAPSULE, SYRUP) of delivery for the medication/product taken. | CMDOSFRM | CMDOSFRM | (FRM) | AEROSOL; CAPSULE; CREAM; GAS; GEL; OINTMENT; PATCH; POWDER; SPRAY; SUPPOSITORY; SUSPENSION; TABLET | 9 | What was the frequency of the medication/product? | Frequency | Record how often the medication/product was taken (e.g., BID, PRN). | CMDOSFRQ | CMDOSFRQ | (FREQ) | BID; PRN; QD; QID; QM; QOD; TID | 10 | What was the route of administration of the medication/product? | Route | Provide the route of administration for the medication/product. | CMROUTE | CMROUTE | (ROUTE) | INTRALESIONAL; INTRAMUSCULAR; INTRAOCULAR; INTRAPERITONEAL; NASAL; ORAL; RECTAL; RESPIRATORY (INHALATION); SUBCUTANEOUS; TOPICAL; TRANSDERMAL; VAGINAL | 11 | What was the start date? | Start Date | Record the date the medication/treatment was first taken using this format. If the subject has been taking the medication/product for a considerable amount of time prior to the start of the study, it is acceptable to have an incomplete date. Medications/Products taken during the study are expected to have a complete start date. Prior medications/products that are exclusionary should have both a start date and an end date. | CMSTDAT | CMSTDTC | 12 | Is the medication ongoing? | Ongoing | Record the medication/product as ongoing if the subject has not stopped taking the medication/product at the time of data collection and the end date should be left blank. | CMONGO | CMENRF OR CMENRTPT | CMENRF or CMENRTPT | (NY) | Yes | 13 | What was the end date? | End Date | Record the date the medication/product was stopped using this format If the subject has not stopped taking the medication/product leave this field blank. | CMENDAT | CMENDTC | |